REGENXBIO Inc. announced the clearance of its Investigational New Drug (IND) application by the United States Food and Drug Administration (FDA) to evaluate RGX-202,...
Valo Therapeutics Oy, the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, announced the acquisition of intellectual property rights from the...
Eat Well Investment Group Inc., is pleased to announce that it’s majority-owned portfolio company, Amara Organic Foods (“Amara”), one of the fastest-growing baby food...
AventaMed DAC, a developer of novel medical devices that streamline surgery, allowing procedures to move out of the operating theatre and into new sites...
